EDGAR Filing Documents for 0001193125-17-323102

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001193125-17-323102

Filing Date

2017-10-27

Accepted

2017-10-27 16:24:26

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-1/A	d445089ds1a.htm	S-1/A	1869930
2	EX-3.3	d445089dex33.htm	EX-3.3	46653
3	EX-3.4	d445089dex34.htm	EX-3.4	119162
4	EX-4.1	d445089dex41.htm	EX-4.1	7181
5	EX-10.5	d445089dex105.htm	EX-10.5	23896
6	EX-10.6	d445089dex106.htm	EX-10.6	23609
7	EX-10.7	d445089dex107.htm	EX-10.7	83455
8	EX-23.1	d445089dex231.htm	EX-23.1	1332
9	GRAPHIC	g445089g22d56.jpg	GRAPHIC	25156
10	GRAPHIC	g445089g24u77.jpg	GRAPHIC	69805
11	GRAPHIC	g445089g27m37.jpg	GRAPHIC	50468
12	GRAPHIC	g445089g42k93.jpg	GRAPHIC	90215
13	GRAPHIC	g445089g51x82.jpg	GRAPHIC	127625
14	GRAPHIC	g445089g63g57.jpg	GRAPHIC	113711
15	GRAPHIC	g445089g67i47.jpg	GRAPHIC	75528
16	GRAPHIC	g445089g92h88.jpg	GRAPHIC	27889
17	GRAPHIC	g445089ima1.jpg	GRAPHIC	394877
18	GRAPHIC	g445089ima2.jpg	GRAPHIC	109867
	Complete submission text file	0001193125-17-323102.txt		3672353

Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014

Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114

Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)